[1] Rini BI, Hutson TE, Figlin RA, et al. Sunitinib in patients with metastatic renal cell carcinoma: clinical outcome according to international metastatic renal cell carcinoma database consortium risk group[J]. Clin Genitourin Cancer, 2018, 16(4):298-304.
[2] Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma[J]. N Engl J Med, 2018, 378(14):1277-1290.
[3] Stephen S. Paraneoplastic cough and renal cell carcinoma[J]. Can Respir J, 2016, 2016:5938536.
[4] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1):7-34.
[5] Liu Y, Pan Y, Zheng W, et al. MiR-186-5p is highly expressed in alcohol-induced cardiomyocytes and regulates apoptosis through the target gene XIAP [J]. Chinese Journal of Bioengineering, 2019 (5): 53-62.(in Chinese)
刘叶, 潘玥, 郑魏, 等. mi-186-5p在酒精诱导的心肌细胞中高表达并通过靶基因XIAP调控细胞凋亡水平[J]. 中国生物工程杂志, 2019(5):53-62.
[6] Luo HSh, Wan YY, Tian X, et al. Expression and mechanism of miR-20a-5p in pancreatic cancer [J]. Journal of Gastroenterology and Hepatology, 2019,28(3):335-340.(in Chinese)
罗和生, 万一圆, 田霞, 等. miR-20a-5p在胰腺癌中的表达及作用机制研究[J]. 胃肠病学和肝病学杂志, 2019,28(3):335-340.
[7] Sun YG, Wang ZhY, Yang YL, et al. MiR-186-5p regulates the reverse mechanism of RAB2A in breast cancer cell doxorubicin resistance by targeting [J]. Chinese Pharmacology Bulletin, 2018, 34 (12): 45-50.(in Chinese)
孙玉国, 王照岩, 杨玉玲, 等. MiR1865p通过靶向调控RAB2A在乳腺癌细胞阿霉素耐药性中的逆转作用机制[J]. 中国药理学通报, 2018, 34(12):4550.
[8] Zhang GX, Xu XW, Meng B, et al. MiR-186-5p inhibits epithelial-mesenchymal transition of lung adenocarcinoma cells through targeted regulation of PTTG1 [J]. Chinese Journal of Biochemistry and Molecular Biology, 2017, (4): 67-72.(in Chinese)
张国新, 徐新伟, 孟斌, 等. miR-186-5p通过靶向调控PTTG1抑制肺腺癌细胞的上皮间质转化[J]. 中国生物化学与分子生物学报, 2017,(4):67-72.
[9] Wang PY, Tian JT, Feng YK, et al. Research progress of the role of MiRNA in reverse cholesterol transport [J]. Chinese Journal of Atherosclerosis, 2018, 26 (10): 1052-1056.(in Chinese)
王鹏宇, 田江天, 冯玉宽,等. MiRNA在胆固醇逆向转运中的作用研究进展[J]. 中国动脉硬化杂志, 2018, 26(10):1052-1056.
[10] Jiang WJ, Fang M, Su JW, et al. Effects and mechanism of MicroRNA-486 and TGF-β1 on calcification of human aortic valve [J]. China Journal of Modern Medicine, 2018, 28 (32): 31-38.(in Chinese)
蒋伟坚, 方明, 苏锦文,等. MicroRNA-486和TGF-β1对人主动脉瓣膜钙化的影响及其机制研究[J]. 中国现代医学杂志, 2018, 28(32):31-38.
[11] Zhang GX, Xu XW, Meng B, et al. MiR-186-5p inhibits epithelial-mesenchymal transition of lung adenocarcinoma cells through targeted regulation of PTTG1 [J]. Chinese Journal of Biochemistry and Molecular Biology, 2017, (4): 380-385.(in Chinese)
张国新, 徐新伟, 孟斌,等. MiR-186-5p通过靶向调控PTTG1抑制肺腺癌细胞的上皮-间质转化[J]. 中国生物化学与分子生物学报, 2017, (4):380-385.
[12] Song D, Wang ZY, Huang P. Expression and role of microRNA-186 in human hepatocellular carcinoma [J]. Cancer, 2017, 37 (7): 750-761.(in Chinese)
宋丹, 王孜尧, 黄平. 微RNA-186在人肝细胞肝癌中的表达及作用[J]. 肿瘤, 2017, 37(7):750-761.
[13] Wang ShX, Zhang ZJ, Yang ShF, et al. Clinical significance of MiRNA expression differences in human kidney cancer cell lines [J]. Chinese Journal of Cancer Prevention and Treatment, 2018, 25 (3): 175-179.(in Chinese)
王世先, 张遵俊, 杨水法,等. 人肾癌细胞株MiRNA表达差异临床意义研究[J]. 中华肿瘤防治杂志, 2018, 25(3):175-179.
[14] Xu LW. The role of MiR-1865p in the invasion, metastasis and angiogenesis of renal clear cell carcinoma [D]. Zhejiang University, 2016: 1-138.(in Chinese)
许力为.MiR-186-5p在肾透明细胞癌侵袭转移和血管生成中作用的研究[D].浙江大学,2016:1-138.
[15] Ma JH. Abnormal mTOR signaling pathway of renal cancer cells and the mechanism of action of everolimus [J]. Chinese Journal of Urology, 2013, 34 (3): 229-231.(in Chinese)
马建辉. 肾癌细胞mTOR信号通路异常与依维莫司作用机制[J]. 中华泌尿外科杂志, 2013, 34(3):229-231.
[16] Guo ShSh, Zhang ZhY, Wang Y. Effects of PI3K/Akt/MTOR signaling pathway on proliferation, migration and invasion of renal cancer A498 cells [J]. Oncology Progress, 2017, 15(12): 1412-1416.(in Chinese)
郭双双, 张治业, 王颖. PI3K/Akt/MTOR信号通路对肾癌A498细胞增殖、迁移及侵袭的影响研究[J]. 癌症进展, 2017, 15(12): 1412-1416.
|